CCL5 as a potential immunotherapeutic target in triple-negative breast cancer

Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

(2011) Gali Soria et al.   BMC CANCER

Relationship Between Clinical and Pathologic Features of Ductal Carcinoma In Situ and Patient Age

(2009) Laura C. Collins et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Synthetic Lethality — A New Direction in Cancer-Drug Development

(2009) J. Dirk Iglehart et al.   NEW ENGLAND JOURNAL OF MEDICINE

The inflammatory chemokines CCL2 and CCL5 in breast cancer

(2008) Gali Soria et al.   CANCER LETTERS

Prediction of Nodal Involvement in Breast Cancer Based on Multiparametric Protein Analyses from Preoperative Core Needle Biopsies of the Primary Lesion

(2008) G. Sauer et al.   CLINICAL CANCER RESEARCH

Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: A basis for tumor-promoting interactions

(2008) Gali Soria et al.   CYTOKINE

What is triple-negative breast cancer?

(2008) William J. Irvin et al.   EUROPEAN JOURNAL OF CANCER